서브메뉴
검색
Computational Design of Peptides as Detectors, Drugs and Biomaterials- [electronic resource]
Computational Design of Peptides as Detectors, Drugs and Biomaterials- [electronic resource]
- 자료유형
- 학위논문
- Control Number
- 0016935179
- International Standard Book Number
- 9798380716024
- Dewey Decimal Classification Number
- 540
- Main Entry-Personal Name
- Sarma, Sudeep.
- Publication, Distribution, etc. (Imprint
- [S.l.] : North Carolina State University., 2023
- Publication, Distribution, etc. (Imprint
- Ann Arbor : ProQuest Dissertations & Theses, 2023
- Physical Description
- 1 online resource(259 p.)
- General Note
- Source: Dissertations Abstracts International, Volume: 85-05, Section: B.
- General Note
- Advisor: Hall, Carol K.
- Dissertation Note
- Thesis (Ph.D.)--North Carolina State University, 2023.
- Restrictions on Access Note
- This item must not be sold to any third party vendors.
- Summary, Etc.
- 요약Computational design of peptides that can (a) recognize/bind to specific protein interfaces and (b) self-assemble into nano-scale architectures such as β-sheet-based fibrils (amyloid) have potential applications in healthcare and advanced biomaterial fabrication. This dissertation focusses on novel computational protocols and their applications to discover peptides that bind to protein targets and form amyloid structures. The key computational steps involved in these protocols are Monte-Carlo based peptide design algorithms (a peptide binding design algorithm, PepBD and a peptideassembly design algorithm , PepAD) to identify potential protein-binding peptides and self-assembling peptides, respectively. Additionally, atomistic molecular dynamics (MD) simulations are used to assess the stability of the designed peptide fibrils and the binding free energy of the peptide-protein complexes. Discontinuous molecular dynamics (DMD) simulation in conjunction with a coarse-grained model, PRIME20, is employed specifically for designing self-assembling peptides to reveal kinetic pathways for fibril formation.Our first study uses our PepBD algorithm and atomistic MD simulations to design peptides that can bind to the SARS-CoV-2 virus. Peptides capable of binding to the Spike-RBD of the Wuhan-Hu-1 strain were identified. In experimental evaluation, three of the five peptides that were synthesized bound to the Spike-RBD of the Wuhan-Hu-1 strain with dissociation constants in the micromolar range, but none of the peptides could outcompete the ACE2:RBD interactions. One peptide, P4, also bound to the SARS-CoV-2 RBD of Kappa-B.1.617.1 and Delta-B.1.617.2 with micromolar affinity. These results demonstrate our ability to design peptides that can recognize the broad spectrum of SARS-CoV-2 RBD variants.Next, we utilized our computational protocol to design 10-mer peptide inhibitors that block Clostridioides difficile toxin A in intestinal cells. We identified peptides that bind to the catalytic site of the Toxin A glucosyltransferase domain (GTD). Two of our in-silicodesigned peptides (NPA and NPB) exhibited lower binding free energies when bound to the TcdA GTD than a reference peptide, RP. In vitro experiments on human jejunum cells confirmed the toxinneutralizing properties of RP and NPA, but the efficacy of NPB was relatively low.Subsequently, we utilized our computational protocol to design 8-mer peptide inhibitors that block C. diff. toxin A in colon cells. (The 10-mer peptides that we designed previously for C. diff. TcdA neutralized C. diff. TcdA toxicity in small intestinal cells but showed no effect in the colon cells). Here, we developed 8-mer peptide inhibitors that block toxin A in both small intestinal cells and colon epithelial cells. Importantly, the designed peptide, SA1, demonstrated neutralization properties against toxin A toxicity in both the small intestine (SI) and colon; it bound toxin A with affinity binding constant KD= 56 ± 29.8 nM.Next, we developed a peptide assembly design (PepAD) algorithm to design peptides that form amyloid-like structures. DMD simulations were employed to reveal the kinetic pathway of fibril formation taken by the in-silicodiscovered peptides. We focused our efforts on designing peptides that form antiparallel amyloid-like structures, specifically the Class 8 cross-β spine described by Sawaya et al. Twelve 7-mer peptides capable of self-assembling into the desired structure were identified. DMD simulations revealed that eight of these peptides spontaneously form amyloid fibrils. Experimental tests confirmed the formation of antiparallel β-sheets at concentrations between 0.2 mM and 10 mM at room temperature in water.
- Subject Added Entry-Topical Term
- Crystal structure.
- Subject Added Entry-Topical Term
- Infections.
- Subject Added Entry-Topical Term
- Toxicity.
- Subject Added Entry-Topical Term
- Severe acute respiratory syndrome coronavirus 2.
- Subject Added Entry-Topical Term
- Cytotoxicity.
- Subject Added Entry-Topical Term
- Mutation.
- Subject Added Entry-Topical Term
- Solvents.
- Subject Added Entry-Topical Term
- Glucose.
- Subject Added Entry-Topical Term
- Decomposition.
- Subject Added Entry-Topical Term
- Amino acids.
- Subject Added Entry-Topical Term
- Design.
- Subject Added Entry-Topical Term
- Energy.
- Subject Added Entry-Topical Term
- COVID-19.
- Subject Added Entry-Topical Term
- Disease transmission.
- Subject Added Entry-Topical Term
- Cellular biology.
- Subject Added Entry-Topical Term
- Toxicology.
- Added Entry-Corporate Name
- North Carolina State University.
- Host Item Entry
- Dissertations Abstracts International. 85-05B.
- Host Item Entry
- Dissertation Abstract International
- Electronic Location and Access
- 로그인을 한후 보실 수 있는 자료입니다.
- Control Number
- joongbu:641108